Conjugated linoleic acid suppresses the secretion of atherogenic lipoproteins from human HepG2 liver cells

References

1 Mangiapane EH, Salter AM. Diet, lipoproteins and coronary heart disease: a biochemical perspective. Nottingham: Nottingham University Press, 1999. Search in Google Scholar

2 Mamo JC, Proctor SD, Smith D. Retention of chylomicron remnants by arterial tissue: importance of an efficient clearance mechanism from plasma. Atherosclerosis 1998; 141: S61–9. 10.1016/S0021-9150(98)00220-2Search in Google Scholar

3 Porth CM, Kunert MP. Pathophysiology: concepts of altered health states, 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2002. Search in Google Scholar

4 Berry EM, Eisenberg S, Horatz D, Friedlander Y, Norman Y, Kaufmann NA, et al. Effects of diets rich in monounsaturated fatty acids on plasma lipoproteins – the Jerusalem Nutritional Study: high MUFAs vs. high PUFAs. Am J Clin Nutr 1991; 53: 899–907. 10.1093/ajcn/53.4.899Search in Google Scholar

5 Dietschy JM. Dietary fatty acids and the regulation of plasma low density lipoprotein cholesterol concentrations. J Nutr 1998; 128: 444S–8S. 10.1093/jn/128.2.444SSearch in Google Scholar

6 Chait A, Onitiri A, Nicoll A, Rabaua E, Davis H, Lewis B. Reduction of serum triacylglyceride levels by polyunsaturated fat. Studies on the mode of action and on very low density lipoprotein composition. Atherosclerosis 1974; 20: 347–64. 10.1016/0021-9150(74)90017-3Search in Google Scholar

7 Cortese C, Levy Y, Janus ED, Turner PR, Roa SN, Miller NE, et al. Mode of action of lipid lowering diets in man: studies of apoprotein B kinetics in relation to fat consumption and dietary fatty acid consumption. Eur J Clin Invest 1983; 13: 79–85. 10.1111/j.1365-2362.1983.tb00068.xSearch in Google Scholar

8 Noone EJ, Roche HM, Nugent AP, Gibney MJ. The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects. Br J Nutr 2002; 88: 243–51. 10.1079/BJN2002615Search in Google Scholar

9 Yotsumoto H, Hara E, Naka S, Adlof RO, Emken EA, Yanagita T. 10-Trans, 12-cis-linoleic acid reduces apolipoprotein B secretion in HepG2 cells. Food Res Int 1999; 31: 403–9. 10.1016/S0963-9969(98)00103-3Search in Google Scholar

10 Pal S, Thomson AM, Bottema CD, Roach PD. Polyunsaturated fatty acids downregulate the low density lipoprotein receptor of human HepG2 cells. J Nutr Biochem 2002; 13: 55–63. 10.1016/S0955-2863(01)00195-4Search in Google Scholar

11 Folch J, Lees M, Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226: 497–509. 10.1016/S0021-9258(18)64849-5Search in Google Scholar

12 Zilversmit DB, Shea TM. Quantitation of apoB-48 and apoB-100 by gel scanning or radio-iodination. J Lipid Res 1989; 30: 1639–46. 10.1016/S0022-2275(20)38247-XSearch in Google Scholar

13 Pal S, Ho N, Santos C, Dubois P, Mamo J, Croft K, et al. Red wine polyphenolics increase LDL receptor expression and activity and suppress the secretion of apoB100 from human HepG2 cells. J Nutr 2003; 133: 700–6. 10.1093/jn/133.3.700Search in Google Scholar

14 Pariza MW, Park Y, Cook ME. Mechanisms of action of conjugated linoleic acid: evidence and speculation. Proc Soc Exp Biol Med 2000; 223: 8–13. 10.1046/j.1525-1373.2000.22302.xSearch in Google Scholar

15 Benito P, Nelson GJ, Kelley DS, Bartolini G, Schmidt PC, Simon V. The effect of conjugated linoleic acid on plasma lipoproteins and tissue fatty acid composition in humans. Lipids 2001; 36: 229–36. 10.1007/s11745-001-0712-xSearch in Google Scholar

16 Alasnier C, Berdeaux O, Chardigny JM, Sébédio JL. Fatty acid composition and conjugated linoleic acid content of different tissues in rats fed individual conjugated linoleic acid isomers given as triacylglycerols. J Nutr Biochem 2002; 13: 337–45. 10.1016/S0955-2863(02)00176-6Search in Google Scholar

17 Banni S, Carta G, Angioni E, Murru E, Scanu P, Melis MP, et al. Distribution of conjugated linoleic acid and metabolites in different lipid fractions in the rat liver. J Lipid Res 2001; 42: 1056–61. 10.1016/S0022-2275(20)31594-7Search in Google Scholar

18 Sugano M, Tsujita A, Yamasaki M, Yamada K, Ikeda I, Kritchevsky D. Lymphatic recovery, tissue distribution, and metabolic effects of conjugated linoleic acid in rats. J Nutr Biochem 1997; 8: 38–47. 10.1016/S0955-2863(96)00150-7Search in Google Scholar

19 Ip C, Chin SF, Scimeca JA, Pariza MW. Mammary cancer prevention by conjugated dienoic derivative of linoleic acid. Cancer Res 1991; 51: 6118–24. Search in Google Scholar

20 Mougious V, Matsakas A, Petridou A, Ring S, Sagredos A, Melissopoulou A, et al. Effect of supplementation with conjugated linoleic acid on human serum lipids and body fat. J Nutr Biochem 2001; 12: 585–94. 10.1016/S0955-2863(01)00177-2Search in Google Scholar

21 Blankson H, Stakkestad JA, Fagertun H, Thom E, Wadstein J, Gudmundsen O. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr 2000; 130: 2943–48. 10.1093/jn/130.12.2943Search in Google Scholar

22 White DA, Bennett AJ, Billett MA, Salter AM. The assembly of triacylglycerol-rich lipoproteins: an essential role for the microsomal triacylglycerol transfer protein. Br J Nutr 1998; 80: 219–29. 10.1017/S0007114598001263Search in Google Scholar

23 Arrol S, Mackness MI, Durrington PN. The effects of fatty acids on apolipoprotein B secretion by human hepatoma cells (HEP G2). Atherosclerosis 2000; 150: 255–64. 10.1016/S0021-9150(99)00374-3Search in Google Scholar

24 Shimano H. Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog Lipid Res 2001; 40: 439–52. 10.1016/S0163-7827(01)00010-8Search in Google Scholar

25 Yu-Poth S, Yin D, Zhao G, Kris-Etherton PM, Etherton TD. Conjugated linoleic acid upregulates LDL receptor gene expression in HepG2 cells. J Nutr 2004; 134: 6–71. 10.1093/jn/134.1.68Search in Google Scholar

26 Forster LF, Stewart G, Bedford D, Stewart JP, Rogers E, Shepherd J, et al. Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates. Atherosclerosis 2002; 164: 129–45. 10.1016/S0021-9150(02)00052-7Search in Google Scholar

27 Scharnagl H, Schinker R, Gierens H, Nauck M, Wieland H, März W. Effect of atorvastatin, simvastatin, and lovastatin on the metabolism of cholesterol and triacylglycerides in HepG2 cells. Biochem Pharmacol 2001; 62: 1545–55. 10.1016/S0006-2952(01)00790-0Search in Google Scholar

28 Thrift RN, Forte TM, Cahoon BE, Shore VG. Characterization of lipoproteins produced by the human liver cell line, HepG2, under defined conditions. J Lipid Res 1986; 27: 236–50. 10.1016/S0022-2275(20)38829-5Search in Google Scholar